nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.491	0.572	CbGaD
Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.367	0.428	CbGaD
Chlorphenamine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00991	0.269	CbGeAlD
Chlorphenamine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00526	0.143	CbGeAlD
Chlorphenamine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00152	0.0413	CbGeAlD
Chlorphenamine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.0015	0.0407	CbGeAlD
Chlorphenamine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00139	0.0379	CbGeAlD
Chlorphenamine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00123	0.0333	CbGeAlD
Chlorphenamine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.00109	0.176	CrCbGaD
Chlorphenamine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.001	0.0273	CbGeAlD
Chlorphenamine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00092	0.025	CbGeAlD
Chlorphenamine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000883	0.024	CbGeAlD
Chlorphenamine—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.000868	0.00878	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000863	0.00872	CbGpPWpGaD
Chlorphenamine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000825	0.0224	CbGeAlD
Chlorphenamine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000813	0.0221	CbGeAlD
Chlorphenamine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000795	0.0216	CbGeAlD
Chlorphenamine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000783	0.0213	CbGeAlD
Chlorphenamine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.00078	0.00789	CbGpPWpGaD
Chlorphenamine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000777	0.0211	CbGeAlD
Chlorphenamine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000756	0.0206	CbGeAlD
Chlorphenamine—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.000737	0.00745	CbGpPWpGaD
Chlorphenamine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000728	0.0198	CbGeAlD
Chlorphenamine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000714	0.00722	CbGpPWpGaD
Chlorphenamine—SLC22A1—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.000687	0.00694	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000686	0.00694	CbGpPWpGaD
Chlorphenamine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000672	0.0183	CbGeAlD
Chlorphenamine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000666	0.0181	CbGeAlD
Chlorphenamine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000664	0.00671	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000643	0.0065	CbGpPWpGaD
Chlorphenamine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000641	0.0174	CbGeAlD
Chlorphenamine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000632	0.00639	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.000631	0.00638	CbGpPWpGaD
Chlorphenamine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000631	0.0171	CbGeAlD
Chlorphenamine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000624	0.00631	CbGpPWpGaD
Chlorphenamine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000622	0.0169	CbGeAlD
Chlorphenamine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0006	0.00607	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.000589	0.00595	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000581	0.00588	CbGpPWpGaD
Chlorphenamine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000578	0.0157	CbGeAlD
Chlorphenamine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000574	0.0925	CrCbGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000558	0.00564	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00054	0.00546	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000531	0.00537	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000524	0.0053	CbGpPWpGaD
Chlorphenamine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000509	0.0138	CbGeAlD
Chlorphenamine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000489	0.00494	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000487	0.00492	CbGpPWpGaD
Chlorphenamine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000479	0.013	CbGeAlD
Chlorphenamine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.000475	0.0048	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000467	0.00472	CbGpPWpGaD
Chlorphenamine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000461	0.0125	CbGeAlD
Chlorphenamine—SLC22A1—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.000443	0.00448	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000443	0.00448	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000413	0.00418	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000413	0.00417	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000407	0.00412	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000399	0.00403	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000376	0.0038	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000373	0.00377	CbGpPWpGaD
Chlorphenamine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000371	0.0101	CbGeAlD
Chlorphenamine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000368	0.0593	CrCbGaD
Chlorphenamine—HRH1—brain—attention deficit hyperactivity disorder	0.000366	0.00996	CbGeAlD
Chlorphenamine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000365	0.00991	CbGeAlD
Chlorphenamine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000361	0.0582	CrCbGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000357	0.00361	CbGpPWpGaD
Chlorphenamine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000357	0.0097	CbGeAlD
Chlorphenamine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000351	0.00954	CbGeAlD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000351	0.00355	CbGpPWpGaD
Chlorphenamine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000343	0.00933	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000343	0.00347	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000342	0.00346	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000339	0.00343	CbGpPWpGaD
Chlorphenamine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000337	0.0543	CrCbGaD
Chlorphenamine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000334	0.0538	CrCbGaD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000329	0.00333	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000326	0.00329	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000319	0.00322	CbGpPWpGaD
Chlorphenamine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000317	0.00321	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000316	0.0032	CbGpPWpGaD
Chlorphenamine—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.0003	0.00303	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.000294	0.0473	CrCbGaD
Chlorphenamine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00029	0.00293	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000289	0.00292	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000288	0.00291	CbGpPWpGaD
Chlorphenamine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000283	0.0455	CrCbGaD
Chlorphenamine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000279	0.00758	CbGeAlD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000269	0.00272	CbGpPWpGaD
Chlorphenamine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000263	0.0423	CrCbGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00026	0.00263	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000258	0.00261	CbGpPWpGaD
Chlorphenamine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000257	0.0414	CrCbGaD
Chlorphenamine—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000256	0.00259	CbGpPWpGaD
Chlorphenamine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000254	0.041	CrCbGaD
Chlorphenamine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.000253	0.0408	CrCbGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000252	0.00255	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000249	0.00252	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.000249	0.0401	CrCbGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000245	0.00247	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00024	0.00243	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000237	0.0024	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.00235	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000232	0.00234	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.000231	0.0372	CrCbGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000228	0.00231	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000227	0.0023	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000227	0.00229	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000226	0.00229	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000226	0.00228	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000214	0.00217	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000211	0.00214	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00021	0.00212	CbGpPWpGaD
Chlorphenamine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00021	0.00212	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0002	0.00203	CbGpPWpGaD
Chlorphenamine—Promazine—DRD2—attention deficit hyperactivity disorder	0.000199	0.0321	CrCbGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000199	0.00201	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000199	0.00201	CbGpPWpGaD
Chlorphenamine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	0.000198	0.0318	CrCbGaD
Chlorphenamine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000197	0.0317	CrCbGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000196	0.00198	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000195	0.00197	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000195	0.00197	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000191	0.00193	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000191	0.00193	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000182	0.00184	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000182	0.00184	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000181	0.00183	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000178	0.0018	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	0.000175	0.0282	CrCbGaD
Chlorphenamine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000174	0.00176	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00017	0.00172	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000169	0.00171	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000164	0.00166	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000162	0.00164	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000162	0.00164	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000161	0.00163	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000158	0.00159	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000155	0.00157	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000154	0.00156	CbGpPWpGaD
Chlorphenamine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000154	0.0248	CrCbGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000153	0.00155	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000153	0.00154	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.00153	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000151	0.00153	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000151	0.00152	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00015	0.00152	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000149	0.00151	CbGpPWpGaD
Chlorphenamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000149	0.00151	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000148	0.0015	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000145	0.00147	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000139	0.00141	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000139	0.0014	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000138	0.00139	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000137	0.00139	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000136	0.00138	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	0.000135	0.0218	CrCbGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000135	0.00137	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000131	0.00132	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000129	0.00131	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000128	0.00129	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000128	0.00129	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000128	0.00129	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000127	0.00128	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000124	0.00125	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000124	0.00125	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000122	0.00123	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.00123	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00012	0.00122	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000118	0.00119	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000116	0.00117	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000116	0.00117	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000115	0.00117	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000115	0.00116	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000112	0.00113	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000112	0.00113	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000111	0.00113	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000111	0.00112	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00011	0.00111	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000106	0.00107	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000105	0.00106	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000104	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000104	0.00106	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000104	0.00105	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000103	0.00104	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000103	0.00104	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000102	0.00103	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	9.81e-05	0.000991	CbGpPWpGaD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.75e-05	0.000985	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.74e-05	0.000984	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9.61e-05	0.000972	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	9.09e-05	0.000919	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.99e-05	0.000909	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.56e-05	0.000865	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	8.46e-05	0.000856	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.38e-05	0.000848	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.36e-05	0.000845	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.25e-05	0.000834	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.09e-05	0.000818	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.98e-05	0.000806	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.95e-05	0.000804	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.92e-05	0.000801	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.87e-05	0.000795	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.86e-05	0.000794	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.86e-05	0.000794	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.77e-05	0.000786	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.61e-05	0.00077	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.32e-05	0.00074	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.84e-05	0.000692	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.73e-05	0.000681	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.65e-05	0.000673	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.35e-05	0.000642	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000641	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.2e-05	0.000627	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.91e-05	0.000597	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.81e-05	0.000587	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.34e-05	0.00054	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.28e-05	0.000533	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.21e-05	0.000527	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.18e-05	0.000523	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.14e-05	0.00052	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.13e-05	0.000518	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.08e-05	0.000514	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.72e-05	0.000477	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.61e-05	0.000466	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000464	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000464	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.57e-05	0.000462	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.5e-05	0.000455	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.5e-05	0.000454	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.44e-05	0.000449	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.41e-05	0.000446	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	4.38e-05	0.000443	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.38e-05	0.000443	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.37e-05	0.000442	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.37e-05	0.000442	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	4.31e-05	0.000436	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.3e-05	0.000435	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.29e-05	0.000434	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.15e-05	0.00042	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.14e-05	0.000418	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.08e-05	0.000413	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.08e-05	0.000412	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.08e-05	0.000412	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.03e-05	0.000408	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.01e-05	0.000405	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.01e-05	0.000405	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4e-05	0.000404	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.76e-05	0.00038	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.73e-05	0.000377	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.5e-05	0.000354	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.5e-05	0.000353	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000337	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000336	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.26e-05	0.00033	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.26e-05	0.000329	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	3.17e-05	0.00032	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.17e-05	0.00032	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000315	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	3.11e-05	0.000315	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.1e-05	0.000314	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.9e-05	0.000293	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.9e-05	0.000293	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.72e-05	0.000275	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	2.65e-05	0.000268	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.65e-05	0.000268	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	2.63e-05	0.000266	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.63e-05	0.000266	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.63e-05	0.000266	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.53e-05	0.000256	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.53e-05	0.000256	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	2.47e-05	0.00025	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.000248	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.45e-05	0.000248	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000244	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000244	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000241	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.25e-05	0.000228	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.25e-05	0.000228	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000224	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.21e-05	0.000224	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.13e-05	0.000216	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.06e-05	0.000208	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.92e-05	0.000194	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.9e-05	0.000193	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.8e-05	0.000182	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.71e-05	0.000173	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000157	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.47e-05	0.000149	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.47e-05	0.000149	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.45e-05	0.000146	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	0.000138	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	0.000137	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.35e-05	0.000136	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.18e-05	0.000119	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	1.14e-05	0.000115	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.14e-05	0.000115	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	0.000113	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	1.06e-05	0.000107	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.92e-06	9.02e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.85e-06	8.95e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.23e-06	8.32e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	8.23e-06	8.32e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.85e-06	5.91e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.82e-06	3.87e-05	CbGpPWpGaD
